glp-1 vs sglt2 weight loss variability with inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities - Brown - 2019 - Obesity Reviews Weight loss differences seen between

h , Mean arterial pressure

Save up to 80% on Trulicity with SingleCare Different pharmacies offer different prices for the same medication

How Many Americans Expect to Use GLP-1s in 2026

GLP-1 drugs may reduce: Frequency of drinking Volume per occasion Desire to drink What this means across the three-tier system Suppliers Monitor changes in premium product demand Evaluate opportunities in lower-ABV and alternative beverages Distributors Watch for shifts in order frequency and product mix Identify regional differences tied to demographics and health trends Retailers On-premise: fewer drinks per visit Off-premise: smaller baskets and substitution effects Why this is a data problem If youre in beverage alcohol, this is a trend you wont see in your dashboardbut you will see it in your data

Medications like Mounjaro and Wegovy are GLP-1 receptor agonists , meaning they're clinically proven to mimic this hormone directly, GLP-1 patches, on the other hand, are not